Greek
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Furocyst - Poly Cystic Ovary Syndrome Study

Μόνο εγγεγραμμένοι χρήστες μπορούν να μεταφράσουν άρθρα
Σύνδεση εγγραφή
Ο σύνδεσμος αποθηκεύεται στο πρόχειρο
ΚατάστασηΟλοκληρώθηκε το
Χορηγοί
Chemical Resources

Λέξεις-κλειδιά

Αφηρημένη

Poly cystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 5%-10% of all females worldwide . PCOS is a hormonal disorder that involves multiple organ systems within the body. Its cardinal features are Hyperandrogenism and polycystic ovary (PCO) morphology. Women with PCOS may complains about irregular menstrual periods or heavy menstrual bleeding, infertility, excessive growth of coarse facial and body hair, obesity, oiliness of the skin, seborrhea, and cystic acne.

Περιγραφή

The symptoms of PCOS are anovulation, resulting in irregular menstruation (amenorrhea and oligomenorrhea) ovulation-related infertility, and polycystic ovaries, often associated with obesity, Type 2 diabetes, and high cholesterol levels. The level of serum insulin and insulin resistance are higher in women with PCOS (Hyperinsulinemia).Insulin resistance, defined as the decreased insulin mediated glucose utilization it is more common in women with PCOS up to 50 % in both obese and non obese women . It has also been recognized that some women with this syndrome will have PCO without clinical evidence of androgen excess, but will display evidence of ovarian dysfunction .

It is believed to be that, the Hyperinsulinemia of PCOS stimulates the androgens production and increase the activity by decreasing the sex hormone binding globulin (SHBG) thus increasing the free active testosterone level and by the activating the cytochrome P 450 C 17 alpha enzymatic system that controls androgens production.

The diagnosis of PCOS is based on Hyperandrogenism and chronic anovulation in the absence of specific pituitary or adrenal disease , and have disrupted ovulatory function with chronic oligomenorrhea (cycle length > 35 day) or amenorrhea (cycle length > 12 week) and typical appearance of polycystic ovaries by ultrasound according to the criteria of the Rotterdam consensus meeting 2003 for diagnosis of PCOS. The different diagnostic tests needed to adequately assess for the possibility of PCOS e.g. Pregnancy test, TSH level (for Hyperthyroidism), Prolactin test (for Hyperprolactinemia), Total testosterone (for ovarian tumor) and some tests forevaluating the insulin resistance syndrome in women: Waist circumference (>88 cm), Triglycerides (>150 mg/dL), HDL Cholesterol (<50 mg/dL), Blood pressure (>130/85) and Fasting glucose (>110 mg/dL). Fasting glucose- to- insulin ratio and 2 hour oral glucose tolerance test (2h- OGTT 140 - 199 mg/dL) may be better predictor of insulin resistance .

The management of the PCOS is symptoms specific e.g.

1. Oral contraceptives, periodic progesterone withdrawal for the control of irregular menstruation.

2. Oral contraceptives, Metformin and anti-androgens (Spironolactone) for the

Hirsutism.

3. Clomiphene citrate, Metformin and thiazolidinediones for infertility. A recent study shown that, the combination of Metformin plus Clomiphene citrate should be considered as the First line treatment for infertile women with PCOS .

4. Metformin and lifestyle modification for the insulin resistance and diabetes mellitus.

All these management options are only for "acute" not for "chronic". The long-term management approach for the PCOS is needed which will be based on management of most affecting factor insulin resistance.

Ημερομηνίες

Τελευταία επαλήθευση: 07/31/2016
Πρώτα υποβλήθηκε: 09/28/2015
Υποβλήθηκε εκτιμώμενη εγγραφή: 03/02/2016
Δημοσιεύτηκε για πρώτη φορά: 03/08/2016
Υποβλήθηκε τελευταία ενημέρωση: 09/13/2017
Δημοσιεύτηκε η τελευταία ενημέρωση: 09/14/2017
Ημερομηνία έναρξης της πραγματικής μελέτης: 03/25/2015
Εκτιμώμενη κύρια ημερομηνία ολοκλήρωσης: 06/30/2017
Εκτιμώμενη ημερομηνία ολοκλήρωσης μελέτης: 06/30/2017

Κατάσταση ή ασθένεια

PCOS

Παρέμβαση / θεραπεία

Dietary Supplement: Furocyst

Φάση

-

Ομάδες βραχιόνων

ΜπράτσοΠαρέμβαση / θεραπεία
Experimental: Furocyst
Furocyst 500mg capsule, BD
Dietary Supplement: Furocyst
Furocyst caps BD

Κριτήρια καταλληλότητας

Επιλέξιμες ηλικίες για μελέτη 18 Years Προς την 18 Years
Φύλα επιλέξιμα για μελέτηFemale
Δέχεται υγιείς εθελοντέςΝαί
Κριτήρια

Inclusion Criteria:

- Premenopausal women between 18-45 years of age and BMI less than 42

- Diagnosed with PCOS by Rottadom Criteria

- Adequate hepatic, renal, Cardiac and hematological functions.

- Patients willing to Participate and give informed consent in writing as well as in audio-visual form for the study.

- Stable weight for last two months (Change of weight<3kg)

Exclusion Criteria:

- Male

- Post menopausal women

- Women with hysterectomy

- Hyperprolactinemia

- Patients with congenital adrenal hyperplasia

- Patients suffering from Cushing's syndrome

- Acute or chronic Medical illness including Hepatic, Cardiac or renal insufficiency, COPD,Gastrointestinal Disorders

- Uncontrolled Hypertensive or known Diabetics on drugs

- Use of oral contraceptives or HRT for last three months

- Smoking or drug addicts or with psychiatric illness

- Patients diagnosed with androgen secreting tumors.

- Patients with thyroid dysfunction (T3, T4 level is higher than that in normal women of reproductive age)

- Patients with Hypo-gonadotropic and Hypo-gonadism (central origin of ovarian dysfunction)

- Pregnant or lactating mothers

Αποτέλεσμα

Πρωτεύοντα αποτελέσματα

1. Reduction in Overian volume & Number of overian Cysts [12 weeks]

Δευτερεύοντα αποτελέσματα

1. Restoration of normal menstrual cycle [12 weeks]

Γίνετε μέλος της σελίδας
μας στο facebook

Η πληρέστερη βάση δεδομένων φαρμακευτικών βοτάνων που υποστηρίζεται από την επιστήμη

  • Λειτουργεί σε 55 γλώσσες
  • Βοτανικές θεραπείες που υποστηρίζονται από την επιστήμη
  • Αναγνώριση βοτάνων με εικόνα
  • Διαδραστικός χάρτης GPS - ετικέτα βότανα στην τοποθεσία (σύντομα)
  • Διαβάστε επιστημονικές δημοσιεύσεις που σχετίζονται με την αναζήτησή σας
  • Αναζήτηση φαρμακευτικών βοτάνων με τα αποτελέσματά τους
  • Οργανώστε τα ενδιαφέροντά σας και μείνετε ενημερωμένοι με την έρευνα ειδήσεων, τις κλινικές δοκιμές και τα διπλώματα ευρεσιτεχνίας

Πληκτρολογήστε ένα σύμπτωμα ή μια ασθένεια και διαβάστε για βότανα που μπορεί να βοηθήσουν, πληκτρολογήστε ένα βότανο και δείτε ασθένειες και συμπτώματα κατά των οποίων χρησιμοποιείται.
* Όλες οι πληροφορίες βασίζονται σε δημοσιευμένη επιστημονική έρευνα

Google Play badgeApp Store badge